Induction chemotherapy in pancreatic cancer: CA 19-9 may predict resectability and survival-Reference-Cited by-同舟云学术

Induction chemotherapy in pancreatic cancer: CA 19-9 may predict resectability and survival

Published:2020-02 Issue:2 Volume:22 Page:224-232
ISSN:1365-182X
Container-title:HPB
language:en
Short-container-title:HPB

Author:

Heger Ulrike,Sun Huihui,Hinz Ulf,Klaiber Ulla,Tanaka Masayuki,Liu Bing,Sachsenmaier Milena,Springfeld Christoph,Michalski Christoph W.,Büchler Markus W.,Hackert Thilo

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference36 articles.

1. Addressing the challenges of pancreatic cancer: future directions for improving outcomes;Hidalgo;Pancreatology,2015

2. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

3. Epidemiology of pancreatic cancer;Ilic;World J Gastroenterol,2016

4. Pancreatic cancer;Kamisawa;Lancet,2016

5. Update on the management of pancreatic cancer: surgery is not enough;Ansari;World J Gastroenterol,2015

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Locally Advanced Pancreas Cancer, Is There a Role for Surgery?;Surgical Clinics of North America;2024-10

2. The Relationship between Treatment Response and Overall Survival in Borderline, Non-Resectable and Resectable Pancreatic Cancer Patients Treated with Neoadjuvant FOLFIRINOX;Journal of Clinical Medicine;2024-09-02

3. Chemotherapy switch for nonresponse or progression on neoadjuvant chemotherapy for pancreatic adenocarcinoma;Journal of Surgical Oncology;2024-08-19

4. Neoadjuvant therapy for localized pancreatic ductal adenocarcinoma;Minerva Surgery;2024-06

5. Differential impact of incrementally elevated CA 19-9 levels on prognosis of resected pancreatic ductal adenocarcinoma;HPB;2024-06